These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 17467922)

  • 1. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.
    Rice DC; Smythe WR; Liao Z; Guerrero T; Chang JY; McAleer MF; Jeter MD; Correa A; Vaporciyan AA; Liu HH; Komaki R; Forster KM; Stevens CW
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):350-7. PubMed ID: 17467922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma.
    Kristensen CA; Nøttrup TJ; Berthelsen AK; Kjaer-Kristoffersen F; Ravn J; Sørensen JB; Engelholm SA
    Radiother Oncol; 2009 Jul; 92(1):96-9. PubMed ID: 19364621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
    Allen AM; Czerminska M; Jänne PA; Sugarbaker DJ; Bueno R; Harris JR; Court L; Baldini EH
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):640-5. PubMed ID: 16751058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience.
    Miles EF; Larrier NA; Kelsey CR; Hubbs JL; Ma J; Yoo S; Marks LB
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1143-50. PubMed ID: 18262369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
    Patel PR; Yoo S; Broadwater G; Marks LB; Miles EF; D'Amico TA; Harpole D; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):362-8. PubMed ID: 22516382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.
    Krayenbuehl J; Oertel S; Davis JB; Ciernik IF
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1593-9. PubMed ID: 17931793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimodality therapy for malignant pleural mesothelioma.
    Buduhan G; Menon S; Aye R; Louie B; Mehta V; Vallières E
    Ann Thorac Surg; 2009 Sep; 88(3):870-5; discussion 876. PubMed ID: 19699914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomy.
    Allen AM; Den R; Wong JS; Zurakowski D; Soto R; Jänne PA; Zellos L; Bueno R; Sugarbaker DJ; Baldini EH
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1366-74. PubMed ID: 17674974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current readings: improvements in intensity-modulated radiation therapy for malignant pleural mesothelioma.
    Rosenzweig KE
    Semin Thorac Cardiovasc Surg; 2013; 25(3):245-50. PubMed ID: 24331147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis.
    Chance WW; Rice DC; Allen PK; Tsao AS; Fontanilla HP; Liao Z; Chang JY; Tang C; Pan HY; Welsh JW; Mehran RJ; Gomez DR
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):149-56. PubMed ID: 25442335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial.
    Rusch VW; Piantadosi S; Holmes EC
    J Thorac Cardiovasc Surg; 1991 Jul; 102(1):1-9. PubMed ID: 2072706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesothelioma at era of helical tomotherapy: results of two institutions in combining chemotherapy, surgery and radiotherapy.
    Sylvestre A; Mahé MA; Lisbona A; Zefkili S; Savignoni A; Bonnette P; Barthes Fle P; Paris E; Perigaud C; Yassa M; Giraud P
    Lung Cancer; 2011 Dec; 74(3):486-91. PubMed ID: 21663996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restricted field IMRT dramatically enhances IMRT planning for mesothelioma.
    Allen AM; Schofield D; Hacker F; Court LE; Czerminska M
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1587-92. PubMed ID: 17892915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
    Rusch VW; Rosenzweig K; Venkatraman E; Leon L; Raben A; Harrison L; Bains MS; Downey RJ; Ginsberg RJ
    J Thorac Cardiovasc Surg; 2001 Oct; 122(4):788-95. PubMed ID: 11581615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma.
    Gomez DR; Hong DS; Allen PK; Welsh JS; Mehran RJ; Tsao AS; Liao Z; Bilton SD; Komaki R; Rice DC
    J Thorac Oncol; 2013 Feb; 8(2):238-45. PubMed ID: 23247629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma.
    de Perrot M; McRae K; Anraku M; Karkouti K; Waddell TK; Pierre AF; Darling G; Keshavjee S; Johnston MR
    Ann Thorac Surg; 2008 Apr; 85(4):1206-10. PubMed ID: 18355497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
    de Perrot M; Uy K; Anraku M; Tsao MS; Darling G; Waddell TK; Pierre AF; Bezjak A; Keshavjee S; Johnston MR
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):111-6. PubMed ID: 17198794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
    Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.
    Yan TD; Boyer M; Tin MM; Wong D; Kennedy C; McLean J; Bannon PG; McCaughan BC
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):619-24. PubMed ID: 19698846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant pleural mesothelioma: surgical management in 285 patients.
    Schipper PH; Nichols FC; Thomse KM; Deschamps C; Cassivi SD; Allen MS; Pairolero PC
    Ann Thorac Surg; 2008 Jan; 85(1):257-64; discussion 264. PubMed ID: 18154820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.